Antibodies News and Research

RSS

Nobel Prize recipient describes on innate immunity at Annual Drosophila Research Conference

A young scientist's astute observation - that grasshoppers don't get sick - eventually led to profound insights into our own immunity.

6 Apr 2013

Study applying OPKO Health's technology to identify synthetic peptoid in NMO patient serum published

OPKO Health, Inc. today announced the publication of a study applying its novel library screening technology to identify a synthetic peptoid that binds to anti-Aquaporin 4 antibodies in the serum of patients with Neuromyelitis optica.

6 Apr 2013

Scientists say detecting single viral protein components challenging for Ebola

By screening a library of a billion llama antibodies on live Ebola viruses in the Texas Biomedical Research Institute's highest biocontainment laboratory, scientists in San Antonio have identified a potential weakness in the make-up of these deadly agents that can immediately yield a sensitive test.

6 Apr 2013

Scientists discover that drinking milk early in life could change how certain genes are expressed

It seems the ads were right. A milk mustache is a good thing to have. Animal and dairy scientists have discovered that drinking milk at an early age can help mammals throughout their lives.

6 Apr 2013

Researchers map immune response to HIV, say findings could inform vaccine science

In research that could help in the search for an HIV vaccine, "American researchers have minutely tracked one person's powerful immune response to the virus to see how a series of mutations led to an antibody that can defeat many HIV strains," the New York Times reports (McNeil, 4/3).

5 Apr 2013

Research: Hepatitis A virus steals membranes from infected cells to protect it from antibodies

Viruses have historically been classified into one of two types - those with an outer lipid-containing envelope and those without an envelope.

5 Apr 2013

Observation of antibody evolution in HIV-1 patient provides insights into vaccine development

Observing the evolution of a particular type of antibody in an infected HIV-1 patient, a study spearheaded by Duke University, including analysis from Los Alamos National Laboratory, has provided insights that will enable vaccination strategies that mimic the actual antibody development within the body.

5 Apr 2013

AIM suppression could help prevent obesity-associated diseases

Obesity is linked to the widespread epidemics of diabetes and heart disease that plague society, but a lesser-known fact is that the weight can also lead to autoimmune disease.

5 Apr 2013

UC San Francisco researchers outline cell-based therapeutics as a "third pillar” of medicine

Treating patients with cells may one day become as common as it is now to treat the sick with drugs made from engineered proteins, antibodies or smaller chemicals, according to UC San Francisco researchers.

4 Apr 2013

CHOP, Pfizer join forces to expedite novel treatments for children

The Children's Hospital of Philadelphia and Pfizer, Inc., are joining forces with the goal of translating biomedical discoveries into novel treatments.

From Pfizer, Inc. 4 Apr 2013

CRG researchers reprogramme lymphoma and leukaemia cells to halt malignancy

Researchers from the Centre for Genomic Regulation (CRG) in Barcelona reprogramme lymphoma and leukaemia cells to halt their malignancy. Resulting cells remain benign even when no longer subjected to treatment and reduce likelihood of developing new tumours.

3 Apr 2013

Doctors give new hope for leukemia patients

Leukemia patients receive a bone marrow transplant, which allows them to build a "new" immune system. However, this immune system not only attacks cancer cells but healthy tissue too.

3 Apr 2013

Antibodies neutralize mosquito-transmitted chikungunya virus, researchers reveal

Researchers have learned the precise structure of the mosquito-transmitted chikungunya virus pathogen while it is bound to antibodies, showing how the infection is likely neutralized.

3 Apr 2013

NewLink Genetics starts Phase 2 clinical study of indoximod in patients with metastatic breast cancer

NewLink Genetics Corporation, a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced the initiation of a double-blind, randomized, placebo-controlled Phase 2 clinical study of its first IDO (indoleamine-(2,3)-dioxygenase) pathway inhibitor, indoximod, in patients with metastatic breast cancer.

2 Apr 2013

New technique for vaccine design could prove useful against HIV, other viral strains

A team led by scientists from The Scripps Research Institute (TSRI) and the International AIDS Vaccine Initiative (IAVI) has unveiled a new technique for vaccine design that could be particularly useful against HIV and other fast-changing viruses.

30 Mar 2013

Researchers find no association between receiving too many vaccines too soon and autism

Although scientific evidence suggests that vaccines do not cause autism, approximately one-third of parents continue to express concern that they do; nearly 1 in 10 parents refuse or delay vaccinations because they believe it is safer than following the Centers for Disease Control and Prevention's schedule.

30 Mar 2013

New concept to fight microorganisms can promote stronger immune system

Managing bacteria and other microorganisms in the body, rather than just fighting them, may be lead to better health and a stronger immune system, according to a Penn State biologist.

29 Mar 2013

A new strategy to protect against HIV infection

An effective vaccine against HIV-1 remains elusive, but one promising strategy focuses on designer antibodies that have much broader potency than most normal, exquisitely specific antibodies.

29 Mar 2013

Penn researchers develop nanotechnology-inspired technique for diagnosing Lyme disease

Early diagnosis is critical in treating Lyme disease. However, nearly one quarter of Lyme disease patients are initially misdiagnosed because currently available serological tests have poor sensitivity and specificity during the early stages of infection.

27 Mar 2013

Genalyte's Maverick Detection System gets CE mark in Europe for research use

Genalyte, Inc. today announced its Maverick Detection System that simultaneously analyzes multiple antibodies and other proteins from a single small sample is now CE marked in Europe for research use.

26 Mar 2013

Antibodies News and Research

Nobel Prize recipient describes on innate immunity at Annual Drosophila Research Conference

Study applying OPKO Health's technology to identify synthetic peptoid in NMO patient serum published

Scientists say detecting single viral protein components challenging for Ebola

Scientists discover that drinking milk early in life could change how certain genes are expressed

Researchers map immune response to HIV, say findings could inform vaccine science

Research: Hepatitis A virus steals membranes from infected cells to protect it from antibodies

Observation of antibody evolution in HIV-1 patient provides insights into vaccine development

AIM suppression could help prevent obesity-associated diseases

UC San Francisco researchers outline cell-based therapeutics as a "third pillar” of medicine

CHOP, Pfizer join forces to expedite novel treatments for children

CRG researchers reprogramme lymphoma and leukaemia cells to halt malignancy

Doctors give new hope for leukemia patients

Antibodies neutralize mosquito-transmitted chikungunya virus, researchers reveal

NewLink Genetics starts Phase 2 clinical study of indoximod in patients with metastatic breast cancer

New technique for vaccine design could prove useful against HIV, other viral strains

Researchers find no association between receiving too many vaccines too soon and autism

New concept to fight microorganisms can promote stronger immune system

A new strategy to protect against HIV infection

Penn researchers develop nanotechnology-inspired technique for diagnosing Lyme disease

Genalyte's Maverick Detection System gets CE mark in Europe for research use

Antibodies eBook

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo